Literature DB >> 19440564

Dysplasia and colitis.

Robert Enns1, Brian Bressler.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19440564      PMCID： PMC2706746          DOI： 10.1155/2009/432069

Source DB:  PubMed          Journal:  Can J Gastroenterol        ISSN： 0835-7900            Impact factor:   3.522


× No keyword cloud information.
  47 in total

1.  Ten year follow up of ulcerative colitis patients with and without low grade dysplasia.

Authors:  C H Lim; M F Dixon; A Vail; D Forman; D A F Lynch; A T R Axon
Journal:  Gut       Date:  2003-08       Impact factor: 23.059

2.  Cancer risk in ulcerative colitis.

Authors:  R G Farmer
Journal:  Scand J Gastroenterol Suppl       Date:  1989

3.  Ursodeoxycholic acid treatment in IBD-patients with colorectal dysplasia and/or DNA-aneuploidy: a prospective, double-blind, randomized controlled pilot study.

Authors:  Urban Sjöqvist; Bernhard Tribukait; Ake Ost; Curt Einarsson; Lena Oxelmark; Robert Löfberg
Journal:  Anticancer Res       Date:  2004 Sep-Oct       Impact factor: 2.480

4.  Most dysplasia in ulcerative colitis is visible at colonoscopy.

Authors:  Matthew D Rutter; Brian P Saunders; Kay H Wilkinson; Michael A Kamm; Christopher B Williams; Alastair Forbes
Journal:  Gastrointest Endosc       Date:  2004-09       Impact factor: 9.427

5.  Dysplasia-associated lesion or mass (DALM) detected by colonoscopy in long-standing ulcerative colitis: an indication for colectomy.

Authors:  M O Blackstone; R H Riddell; B H Rogers; B Levin
Journal:  Gastroenterology       Date:  1981-02       Impact factor: 22.682

6.  Pancolonic indigo carmine dye spraying for the detection of dysplasia in ulcerative colitis.

Authors:  M D Rutter; B P Saunders; G Schofield; A Forbes; A B Price; I C Talbot
Journal:  Gut       Date:  2004-02       Impact factor: 23.059

7.  Dysplasia and carcinoma in longstanding ulcerative colitis: an endoscopic and histological surveillance programme.

Authors:  M Leidenius; I Kellokumpu; A Husa; M Riihelä; P Sipponen
Journal:  Gut       Date:  1991-12       Impact factor: 23.059

8.  Long-term follow-up after polypectomy treatment for adenoma-like dysplastic lesions in ulcerative colitis.

Authors:  Robert D Odze; Francis A Farraye; Jonathan L Hecht; Jason L Hornick
Journal:  Clin Gastroenterol Hepatol       Date:  2004-07       Impact factor: 11.382

9.  Combined alpha-methylacyl coenzyme A racemase/p53 analysis to identify dysplasia in inflammatory bowel disease.

Authors:  Andreas Marx; Timo Wandrey; Philipp Simon; Agatha Wewer; Tobias Grob; Uta Reichelt; Sarah Minner; Ronald Simon; Martina Spehlmann; Wolfgang Tigges; Nib Soehendra; Uwe Seitz; Stefan Seewald; Jakob R Izbicki; Emre Yekebas; Jussuf T Kaifi; Martina Mirlacher; Luigi Terracciano; Achim Fleischmann; Andreas Raedler; Guido Sauter
Journal:  Hum Pathol       Date:  2008-10-05       Impact factor: 3.466

10.  Precancer and cancer in extensive ulcerative colitis: findings among 401 patients over 22 years.

Authors:  J E Lennard-Jones; D M Melville; B C Morson; J K Ritchie; C B Williams
Journal:  Gut       Date:  1990-07       Impact factor: 23.059
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.